NHSE approves NICE access to Rx-info medicines data

Rx-info is delighted to announce that NICE have access to hospital medicines data to assist with their scoping work.

An agreement between NHS England and NICE has provided access to Rx-info Define secondary care medicines data which will assist in analysing the usage and uptake of new medicine technologies.

Colin Richman, Company Director at Rx-info said “We have been in discussion with the Define national license holder NHSE to provide NICE access to this vital data set.  This access will augment the excellent scoping work that NICE does and allow for a greater understanding of the context of how medicines are used in hospitals”.